Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22.591
Filtrar
Adicionar filtros

Intervalo de ano
1.
J Endod ; 2022 Jul 12.
Artigo em Inglês | MEDLINE | ID: covidwho-2036304

RESUMO

INTRODUCTION: There is lack of data on whether the coronavirus disease 2019 (COVID-19) pandemic was associated with changes in the etiology of pathosis in endodontic patients. The aim of this study was to determine the rate of cracks and other etiologic factors during the period of March 16th to May 31st in 2020 (COVID-19 initial outbreak) and 2021 (COVID-19 ongoing pandemic) compared with figures from the same period in 2019 (pre-COVID era) in 2 endodontists' practices. METHODS: The etiologies of patients' chief complaints were determined from records of 2440 teeth (740 in 2019, 651 in 2020, and 1049 in 2021). Changes in the proportion of etiologic factors among all 3 periods were analyzed. The association between the rate of cracked teeth and patients' age and sex was determined using a logistic regression model. RESULTS: The rates of all etiologies collectively during the studied periods showed a significant change (P < .0001). The rate of cracks significantly increased in 2020 (11.8%) (P = .0001) and 2021 (8%) (P = .0018) compared with 2019 (4.3%). The rate of persistent infections decreased in 2020 (22.3%) (P = .0013) and then increased in 2021 (27.5%) (P = .0153) compared with 2019 (30%). Cracked teeth were associated with the age group of 40-60 years (odds ratio [OR] = 1.882; 95% confidence interval [CI], 1.063-3.330) in 2020 and with age ranges of 40-60 years (OR = 2.051; 95% CI, 1.120-3.759) and >60 years (OR = 2.038; 95% CI, 1.050-3.956) and male sex (OR = 1.599; 95% CI, 1.019-2.510) in 2021. CONCLUSIONS: The rate of cracked teeth increased during the initial outbreak of the COVID-19 pandemic and 1 year later. This study provided evidence on the association between the COVID-19 pandemic and changes in the rate and presentation of endodontic etiologic factors.

3.
Tourism Management Perspectives ; 43(30), 2022.
Artigo em Inglês | CAB Abstracts | ID: covidwho-2036583

RESUMO

Since the arrival of COVID-19, tourism scholarship has focused its attention on rethinking and restarting the tourism sector. In this urgent search for a 'new normal', the embodied experience of hosting such an unwelcomed virus, the philosophical questions this raises, and the tourism futures already in the making, have not been fully explored. The article introduces Nancy's (2000/2002) philosophy, L'intrus [The Intruder], where he reflects on having a heart transplant operation to give body to the experiences of the self as exteriority and of otherness always already within. We take inspiration from Nancy to think and sense the experience of the COVID-19 virus intrusion in tourism. To do this, we weave personal philosophical reflections with ethnographic material to reflect on three themes of intrusion for tourism scholarship to consider: the experience of a body/self as exposed, the experience of a shattered self, and the experience of uncertain futures.

4.
Annals of Oncology ; 33(Suppl. 3):S234-S234, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035758

RESUMO

Background: COVID-19 pandemic brought pressure to Portuguese National Health Service (NHS). We aim to assess pandemic impact on diagnosis and management of breast cancer (BC) in a high-volume Portuguese comprehensive cancer centre, which was classified as a COVID-free institution by public health authorities.

5.
Annals of Oncology ; 33(Suppl. 3):S230-S230, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035757

RESUMO

Background: Cancer patients are more sensitive to infection induced by SARS-CoV-2, especially ones with impaired immune response. Vaccines are approved as safe and effective, and they are recommended in oncology patients. The aim of our study was to see the percentage of reinfections after second dose of vaccines against SARS-CoV2.

6.
Annals of Oncology ; 33(Suppl. 3):S225-S225, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035756

RESUMO

Background: The COVID-19 pandemic has led to more than 260 million infections and 55 million deaths as of early December 2021, worldwide. Vaccinating people against COVID-19 is considered as he best approach to overcome the pandemic since COVID 19-vaccines are effective and can reduce the risk of getting and spreading the virus. However, their efficacy and safety in patients with underlying disease such as cancers have not been approved yet. Here we report a cohort study on immunogenicity and safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with breast cancer, who were vaccinated as a part of a national plan for vaccination of patients with special diseases.

7.
Annals of Oncology ; 33(Suppl. 3):S224-S224, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035755

RESUMO

Background: COVID-19 has impacted every aspect of our lives. Flooding of hospitals with COVID-19 patients have affected quality of care given to breast cancer patients. Our aim is to assess the impact of COVID-19 on presenting cases of breast cancer and worsening of breast cancer stage and/or TNM classification.

8.
Annals of Oncology ; 33(Suppl. 3):S190-S190, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035754

RESUMO

Background: Breast cancer (BC) ranks first in the structure of cancer incidence among women in Kazakhstan. Mammography screening was implemented in 2008. Lockdowns and restrictive procedures with the full and partial cancellation of screening, took place in Kazakhstan in 2020-2021.

9.
Annals of Oncology ; 33(Suppl. 3):S189-S190, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035753

RESUMO

Background: The epidemic start of Coronavirus disease it expanded in the first months of 2020. Italy was among the first European countries to be affected and those affected more intensely: the first case was reported on 02.20.2020 The entire health system has been disrupted and reorganized due to the impact of the pandemic on hospitals The suspension of first-level screening services in Italy occurred in the months of March and April 2020 on throughout the national territory, starting from May 2020 the screening programs were reactivated albeit with different timing and intensity between the regions and within of each single region.

10.
Annals of Oncology ; 33(Suppl. 3):S173-S173, 2022.
Artigo em Inglês | GIM | ID: covidwho-2035751

RESUMO

Background: COVID-19 pandemic motivated a reorganization of healthcare institutions, which may have led to a negative impact on cancer patients' treatment. This study compared the pathological response (PR) rate to neoadjuvant chemotherapy (NACT) in breast cancer (BC) patients who underwent treatment before (BCv) and during (DCv) the COVID-19 pandemic at our institution.

11.
Annals of Emergency Medicine ; 78(4 Suppl):S161-S162, 2021.
Artigo em Inglês | GIM | ID: covidwho-2035743

RESUMO

Study Objectives: The COVID-19 pandemic has demonstrated that social determinants of health (SDOH) are profoundly linked to the spread and outcomes of COVID-19. However, the relationships between these SDOH and COVID-19 spatial outbreaks have yet to be determined. We conducted spatial analyses with geographic information systems (GIS) mapping of county-level SDOH and regional COVID-19 infection outbreaks to demonstrate the most impactful SDOH and to provide a pragmatic visual guide to prevent future outbreaks.

12.
Annals of Emergency Medicine ; 78(4 Suppl):S106-S106, 2021.
Artigo em Inglês | GIM | ID: covidwho-2035724

RESUMO

Study Objectives: A non-food-borne hepatitis A outbreak occurred in Michigan between August 2016 and September 2019, resulting in 920 cases, 738 hospitalizations, and 30 deaths. To support the Michigan Department of Health and Human Services' efforts to increase hepatitis A vaccination rates among high-risk individuals, our multicenter health system implemented an electronic medical record (EMR)-based vaccination intervention across its nine emergency departments (ED). The primary objective of this retrospective cohort and survey analysis was to quantitatively determine whether this intervention was successful in increasing vaccination rates. The secondary objective was to qualitatively assess the attitudes towards, and barriers to use of, the computerized vaccine reminder system.

13.
Annals of Emergency Medicine ; 78(4 Suppl):S79-S79, 2021.
Artigo em Inglês | GIM | ID: covidwho-2035717

RESUMO

Study Objective: D-dimer utility in diagnosing pulmonary embolism (PE) in the setting of COVID-19 has not been clearly established. Patients presenting with COVID-19 are screened for disease severity with d-dimer. The primary outcome of this study was to evaluate the test characteristics of d-dimer assay for the exclusion of PE in patients with COVID-19 in both the academic and community setting.

14.
Indian Pediatrics ; 59(5):424-425, 2022.
Artigo em Inglês | CAB Abstracts | ID: covidwho-2035429

RESUMO

Lactating mothers (n=126) residing in Pune, Maharashtra were interviewed to assess the prevalence of stress, rate of exclusive breastfeeding (EBF), and its association with different demographic factors. 75.4% mothers were found to be moderately stressed. Rate of EBF was 62.7%. Moderate stress and testing positive for COVID-19 were significantly negatively associated with EBF (P < 0.001).

15.
Food Science & Technology ; 35(1):28-31, 2021.
Artigo em Inglês | CAB Abstracts | ID: covidwho-2034779

RESUMO

The aim of the article was to provide an update on recommendations made in a IUFoST study on the contribution of food science and technology to sustainable nutrition. The added immediate impact of the COVID-19 pandemic is also examined, as well as providing update of the previous recommendations for action within the food chain to improve global diet and health via innovation in food manufacture and distribution. The arrival of the global COVID-19 pandemic has changed the expected routes for their implementation but has accelerated the need for these actions. However, they do not believe that their long-term overall importance has been changed. Global harmonisation will be necessary and should probably relate to the nutrient availability within foods, not just their type or brand. Like manufacturing, distribution also benefits from economies of scale and responds to consumer demand. There are already signs that manufacturers and retailers of finished foods will drive future branding via health benefits as well as the eating quality and cost. The pandemic is accelerating these trends, and it is likely that legislation will devote greater attention to nutrient values.

16.
Vestnik Rossiyskoy voyenno meditsinskoy akademii ; 4:147-152, 2021.
Artigo em Russo | GIM | ID: covidwho-2034544

RESUMO

The article presents the results of a study of the immunogenicity and reactogenicity of the vaccine Gam-COVID-Vac (Sputnik V) when used in military personnel undergoing military service on conscription. From 300 military personnel consistently vaccinated with one and two components of Gam-COVID-Vac at the intervals of 21 days, blood serum was obtained and examined three times: before vaccination, and 30 and 60 days after the introduction of the first component of the vaccine. In the blood serums, the content of Class G antibodies to the SARS-CoV-2 was determined by the method of solid-phase enzyme immunoassay. After immunization with the Gam-COVID-Vac vaccine, the average geometric titer of Class G antibodies to SARS-CoV-2 -in the blood serum of a military personnel obtained during the second and third examinations (5.02 log2 and 5.67 log2) increased by 2.4 and 2.7 times, respectively (p < 0.05), compared to the same indicator before the vaccination (2.11 log2). Total of 30 days after the introduction of the first component of the vaccine (Nine days after the introduction of the second component of the vaccine), Class G antibodies to the new coronavirus SARS-CoV-2 were detected in the 86.7% of military personnel, and after 60 days - in 92% of vaccinated. Studies have revealed moderate reactogenicity of the vaccine. Moreover, the proportion of postvaccination reactions in the first 3-5 days after the introduction of the second component of the vaccine was less after the introduction of the first component of the vaccine. So, if after the introduction of the first component of the vaccine, an increase in body temperature > 37 degrees C was observed in 20% of military personnel, then after the introduction of the second component only in 9%, and the share of local reactions decreased from 9-4%. There have been no cases of serious adverse events after immunization of military personnel with the Gam-COVID-Vac vaccine.

17.
Fresenius Environmental Bulletin ; 30(11A):12224-12229, 2021.
Artigo em Inglês | GIM | ID: covidwho-2034538

RESUMO

To evaluate the safety and efficacy of albuvirtide (ABT) in the treatment of patients with Coronavirus Disease 2019 (COVID-19). The study was conducted in 22 patients with laboratory-confirmed COVID-19 infections in the Public Health Clinical Center of Chengdu from February to April, 2020. All patients intravenously received 320 mg of ABT on Day 1, 2, 3, 8 in addition to standard care. The primary endpoint was a coronavirus-negative result and the pneumonia was alleviated in patients. It showed that the average age of the patients was 48.2 +or- 18.0 years old, and 10 of them (45.5%) were male. The most common symptoms were cough (81.8%), expectoration (72.7%), fever (27.3%), while no abnormal blood cell count was observed among these patients. The CT examination showed that 6 patients (27.3%) with unilateral pneumonia and 15 of them (68.2%) with bilateral pneumonia, confirmed by massive patchy shadows and ground glass opacities within patient lungs. After the ABT treatment, the cough, expectoration and fever were relieved by 33.3%, 43.8% and 100%, respectively. The mean body temperature recovery time was 2.5 days (range, 1-4 days). The alleviated pneumonia was seen in 14 patients (63.6%) by CT scanning after day 8. Based on nasopharyngeal sampling, the COVID-19 RNA was negatively detected in 14 of 22 patients after 8 days of ABT treatment. Meanwhile, no obvious adverse events occurred during and after treatment. The results showed that ABT presents a favorable clinical response in patients infected with COVID19.

18.
Journal of Food Safety and Quality ; 13(6):1974-1982, 2022.
Artigo em Chinês | CAB Abstracts | ID: covidwho-2034537

RESUMO

Since the 1990s, food safety has caused widespread concern from all walks of life. According to the theory of bibliometrics and scientific knowledge map and knowledge mining method, this paper quantitatively analyzed and visualized 3024 food safety papers and 31032 references in the core collection of Web of Science (WoS) to explore their research status, topic evolution and development trend. The number of academic papers in the field of international food safety increased by 11 times during the past 31 years;the knowledge structure of this field consists of foodborne pathogenic bacteria, food safety cognition, public health and food safety management;its research topics showed an evolution from consumer behavior and food-borne diseases to food safety risk management, food safety governance, food traceability system, food testing, to food global value chain, heavy metal excess, pesticide residues, food safety culture, to blockchain technology, Corona virus disease 2019 (COVID-19) epidemic, food fraud;food safety knowledge and willingness to pay premium, food contamination, aquatic seafood safety, vegetable safety, blockchain, COVID-19 represent the frontier trends, so as to provide references for academic research and government supervision in this field.

19.
Chinese Journal of Nosocomiology ; 32(12):1812-1816, 2022.
Artigo em Inglês, Chinês | GIM | ID: covidwho-2034536

RESUMO

OBJECTIVE: To investigate and analyze the genotyping, virulence genes and drug-resistant genes of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from skin and soft tissue infections in this area. METHODS: The skin secretions of 204 patients with skin and soft tissue infections in the Fifth Central Hospital of Tianjin between Jan. 2019 and Dec. 2020 were collected, and MRSA strains identified as non-repetitive strains were isolated. The Staphylococcal cassette chromosome mec (SCCmec) and Staphylococcal protein A gene (spa) genotyping and Panton-valentine leukocidin (PVL) gene carrying status were analyzed among the MRSA strains, and their relationship with drug resistance was analyzed. RESULTS: Totally 82 strains of S. aureus were isolated from the skin secretions of 204 patients with skin and soft tissue infections, including 44 strains of MRSA (53.66%). The most common SCCmec genotype was genotype III (accounting for 84.09%) and the most common spa genotype was genotype t030 (accounting for 84.09%). PVL genes encoding virulence factors were amplified in 5 strains (11.36%). The drug resistance rates of 44 MRSA strains to vancomycin and compound sulfamethoxazole were 0.00%, and all the strains were drug-resistant to penicillin. Different SCCmec and spa genotypes were highly resistant to erythromycin, cefazolin, clindamycin and levofloxacin, but the differences in drug resistance rates of different SCCmec genotypes to clindamycin and levofloxacin were significant (P < 0.05). The resistance rates of strains with PVL positive genes to chloramphenicol, gentamicin and tetracycline were significantly higher than those with PVL negative genes (P < 0.05). CONCLUSION: Strains carrying SCCmec III and spa t030 genotypes may be the dominant strains of MRSA in skin and soft tissue infections in this area. Spa genotypes and PVL gene have certain impact on drug resistance of MRSA, and the isolated MRSA strains are all sensitive to vancomycin and compound sulfamethoxazole, which can provide a reference for anti-MRSA treatment in this area.

20.
Lancet Infectious Diseases ; 22(6):762-763, 2022.
Artigo em Inglês | CAB Abstracts | ID: covidwho-2034525

RESUMO

This article reported an astounding drop in dengue risk in 2020 attributable to public health and social measures during the pandemic. Taking population immunity into account, this study acknowledged how the unprecedented dengue burden of 2019 might have driven high immunity to dengue in 2020. This study also mentioned idiosyncrasies in the model that could not be explained. Moreover, it also adds possible considerations of (1) administrative delays and (2) genotype-replacement events driving the 2019 epidemics affecting conclusions drawn from the model. Therefore, the greatest dengue year on record in 2019, in terms of incidence, be treated as unique in that it was probably fuelled by viral evolutionary events resulting in genotype replacements and might falsely augment the differential dengue virus burden between a higher-than-usual 6-year mean dengue incidence (inclusive of 2019) versus the comparison year of 2020. From an academic standpoint, this study would be curious to see how the model would perform if the outlier year of 2019 were removed.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA